BBB. O. Bembeeva

B. O. Bembeeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


B. O. Bembeeva has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of Antimicrobial Therapy on the Development of Microbiota in Infants

    by Tatiana Priputnevich, Pavel Denisov, Ksenia Zhigalova, Vera Muravieva, Natalia Shabanova, Alexey Gordeev, Viktor Zubkov, Bayr Bembeeva, Elena Isaeva, Anastasia Nikolaeva, et al.

    Background. The establishment and diversity of the gut microbiota during early childhood are fundamental for immune regulation and metabolic processes, with factors such as prematurity, delivery method, antibiotic treatment, and breastfeeding significantly impacting microbiome development and potential health outcomes. Objectives/Methods. This comparative study examined the gut microbiota composition in children aged 6–8 and 9–12 months, born via spontaneous labor at ≥38 weeks’ gestation, who either did not receive antibacterial therapy or required beta-lactam antibiotics. The composition of the colonic microbiota was analyzed in these fecal samples using a quantitative real-time PCR (qRT-PCR). Results. Significant differences in microbiota composition were observed between groups. Children treated with antibiotics exhibited a statistically significant reduction in alpha diversity indices (Shannon and Simpson), along with decreased colonization of key functionally important microorganisms, including obligate anaerobic bacteria such as Faecalibacterium prausnitzii, Clostridium leptum, Bacteroides spp., and metabolically active Bifidobacteria (B. bifidum, B. breve, B. longum). Conclusions. These microbiota alterations may adversely affect child health by diminishing microbial balance and functional potential, especially during this critical period of immune and metabolic development. The decline in anti-inflammatory, short-chain fatty acid-producing bacteria elevates the risk for allergic, atopic, dysbiotic, and metabolic conditions. Recognizing these impacts underscores the importance of strategies to supports microbiota restoration after antibiotic use, such as probiotics, prebiotics, and dietary interventions. Further research should focus on microbiota recovery dynamics to facilitate early intervention and optimize pediatric health outcomes. Overall, understanding antibiotic effects on gut microbiota can guide more judicious treatment approaches, reducing long-term health risks.

  • Open Access

    Optimising Conditions for the Preservation of Extremely Oxygen Sensitive Obligate Anaerobes of the Gut Microbiota as Candidates for Probiotic Strains

    by Б. О. Бембеева, E. L. Isaeva, V. V. Muravieva, K. N. Zhigalova, O. V. Nechaeva, D. Kh. Bazukheyr, T. V. Priputnevich, Д. Х. Базухейр

    Obligate anaerobic difficult culture bacteria, which make up the bulk of the microbiota of the large intestine, are potential candidates for the development of highly effective new generation probiotics, since they are capable of synthesizing a variety of metabolites, including short-chain fatty acids, which have a stimulating effect on both commensal bacteria and host cells. However, for their long-term preservation, it is necessary to carefully select the preservation method and protective components. To evaluate the efficacy of using different cryoprotectants to increase the viability of obligate anaerobic difficult culture bacteria when preserved by lyophilisation and cryopreservation methods. The studies showed that freeze-drying contributed most to the preservation of the viability of Faecalibacterium prausnitzii, Anaerostipes hadrus, Eubacterium hallii, provided that they were used as a stabilizing medium, which included inulin, cysteine and riboflavin, ensuring the preservation of the initial bacterial titer for 30 days. Among the studied bacteria, the effectiveness of cryopreservation was shown for A. hadrus, since it ensured the survival of bacteria at the initial level for 14 days of storage, regardless of the cryopreservative used, but by the 30th day their viability decreased significantly (by 100 times when using liquid as a cryopreservant). nutrient medium 110 with minced meat and carbohydrates with the addition of glycerin, 10 000 with the commercial cryopreservative CRYOINSTANT). The results obtained allow us to recommend lyophilization as the most optimal method for long-term storage of probiotic strains of bacteria using highly effective stabilizers.


  • Open Access

    Effect of COVID-19 on the Gut Microbiota of Pregnant Women (review)

    by B. O. Bembeeva, T. V. Priputnevich, N. V. Dolgushina

    The Novel coronavirus infection (COVID-19) pandemic has shown that pregnant women are at risk for infection and severe COVID- 19. Pregnant women often experience gastrointestinal symptoms both during the peak of the disease and within 90 days after recovery. This review is devoted to the study of the effect of the SARS-CoV-2 virus on the gut microbiota of pregnant women. Since many studies confirm changes in the composition of the gut microbiota in COVID-19, the dependence of the severity of the course of infection on the composition of the gut microbiota, and the persistence of the virus in the gut after recovery. The question remains whether the composition of the intestinal microbiota changes in pregnant women and newborns during COVID-19, and whether it is possible to correct the state of intestinal dysbiosis during COVID-19 with probiotics for the purpose of prevention and treatment of pregnant women and newborns.

  • Analysis of the Antimicrobial Activity of Epigallocatechin-3-Gallate (EGCG)

    by V. V. Muravieva, B. O. Bembeeva, T. V. Priputnevich, V. I. Kiselev

    We studied antimicrobial activity of epigallocatechin-3-gallate (EGCG), a green tea polyphenolic catechin, and its combined use with ceftazidime (CAZ) agai


  • Development of the gut microbiota of term and late preterm newborn infants

    by T.V. Priputnevich, E.L. Isaeva, V.V. Muravieva, M.K. Mesyan, V.V. Zubkov, A.V. Nikolaeva, B.O. Bembeeva, L.A. Timofeeva, A.A. Kozlova, S.M. Yudin

    Становление микробиоты кишечника доношенных и поздних недоношенных детей, рожденных самопроизвольно и путем операции кесарева сечения


  • Necrotizing enterocolitis in extremely low birth weight infants and associated risk factors: a retrospective analysis

    by O.V. Ionov, D.R. Sharafutdinova, E.N. Balashova, A.R. Kirtbaya, E.E. Kosterina, M.N. Shakaya, M.B. Bezlepkina, A.YU. Ryndin, T.V. Priputnevich, B.O. Bembeeva, et al.

    Факторы, ассоциированные с развитием некротизирующего энтероколита у новорожденных с экстремально низкой массой тела при рождении: ретроспективный